Recent News for ALNA - Allena Pharmaceuticals, Inc.

Date Title
Mar 13 Allena Pharmaceuticals (ALNA) Presents At Cowen and Company 39th Annual Health Care Conference - Slideshow
Mar 7 Allena Pharmaceuticals reports Q4 results
Mar 7 Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
Mar 5 Allena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference
Feb 4 Allena Greatly Improves Phase III Design Endpoint Support, Improving Sentiment
Feb 1 45 Stocks Moving In Friday's Mid-Day Session
Jan 4 Allena Pharmaceuticals appoints Louis Brenner as CEO
Jan 4 Allena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019
Jan 2 45 Stocks Moving In Wednesday's Mid-Day Session
Jan 2 Allena Pharmaceuticals aligns with FDA on phase 3 program and accelerated approval pathway for reloxaliase in enteric hyperoxaluria
Jan 2 Allena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria
Dec 24 Do Hedge Funds Love Allena Pharmaceuticals, Inc. (ALNA)?
Dec 19 The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
Dec 3 Allena Pharma files for $200M mixed shelf offering
Nov 19 Recent Analysis Shows Arcimoto, ADOMANI, Lipocine, Aileron Therapeutics, Allena Pharmaceuticals, and Perma-Fix Environmental Services Market Influences — Renewed Outlook, Key Drivers of Growth
Nov 7 Allena Pharmaceuticals EPS in-line
Nov 7 Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
Nov 6 Allena Pharmaceuticals to Present at Upcoming Investor Conferences in November
Oct 25 Allena Pharmaceuticals to Present Data Characterizing Significant Unmet Need in Enteric Hyperoxaluria at ASN Kidney Week 2018
Oct 22 Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346
Oct 18 Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings
Sep 25 Allena Pharmaceuticals to Present at Upcoming Investor Conferences in October

Back to the Main ALNA Page...